Hi Vineet, Thanks for putting up these questions.
Regarding the 1st question, the company has mentioned in its presentation that exports in Acrylamide at 14000 capacity earlier already used to account for 45% sales and it has penetrated into US markets as well…so I don’t think there is need to worry about surplus capacity in domestic markets as the company has a balanced geographical approach in Acrylamide.
Disc: invested